Total glycosylated haemoglobin was determined by a minicolumn ion-exchange chromatography technique (BioRad) and correlated with the mean of fasting and post-prandial blood glucose values for the preceding 6 weeks. In 360 diabetic subjects, free of congenital haemoglobinopathies and other detected causes of haemoglobin A1 misinterpretation (reference diabetic group), a highly significant correlation was established between haemoglobin A~ and glucose (y = 0.54 • + 4.91; r = 0.791; p < 0.01). In 28 of the 29 patients with heterozygous haemoglobinopathies (HbS, C, D, E), the apparent haemoglobin A1 values were lower than expected according to the 95% confidence limits of the diabetic reference group. The apparent haemoglobin A1 value was above these limits in patient 29, with [~ thalassaemia. Patients with inappropriate glycosylated haemoglobin values should be investigated for causes of haemoglobin A1 misinterpretation, in particular, haemoglobinopathies.
The determination of glycosylated haemoglobin (HbAtc) has become a widely used index for the assessment of diabetic control [1] . The rapid determination by minicolumn chromatography of a fast migrating group of fractions, termed HbA1, is convenient and readily available [2] . Erroneous interpretations may be due to various pathophysiological and pharmacological interferences [3] .
The aim of the present study was to define how the measurement of HbA1 is affected by the presence of congenitally abnormal haemoglobins [4] [5] [6] [7] [8] [9] [10] .
Subjects and methods

Subjects
A total of 389 diabetic subjects were studied: 360 were free of congenitally abnormal haemoglobin (diabetic reference group); 29 others had congenital haemoglobinopathy, as described below. Both groups were similar in age (45 + 5 versus 50 + 5 years; mean + SEM), sex ratio (190/170 versus 18/11) and the percentage of insulin dependence (50% versus 55%). Patients with either recurrent hypoglycaemia, shortened erythrocyte life-span or renal failure were excluded.
Laboratory methods
HbAv The HbA1 fraction was determined by a rapid minicolumn chromatography technique (Bio-Rad, Richmond, California, USA). The heparinized venous blood samples were haemolyzed with polyoxyethylene ether 0.33% (v/v), put on the Biorex resin column (25 mm• 7 ram, Bio-Rad), then eluted at 22 + t ~ with phosphate buffer (pH 6.7, 0.01 tool/l). The optical density of eluates was read at 415 nm. The percentage of HbA1 was calculated in comparison with total haemoglobin. The HbA1 value, measured in 30 non-diabetic subjects, was 6.7 _+ 0.7% of total haemoglobin.
Haemoglobin studies: Electrophoresis was performed by two different migrating systems [11] , both from Helena, Beaumont, Texas: (t) on cellulose acetate plates using a Tris/EDTA/boric acid buffer (pH 8.6), and (2) on agar gel with a citrate/citric acid buffer (pH 6.0).
Further identification of HbS was made by a precipitation test [12] . Heterozygous thalassaemia was diagnosed by the typical haematological (microcytosis) and electrophoretic patterns: high HbA2 (9%) and HbF (3%), and the alkaline denaturation test [13] . The variants HbD and HbE were identified by direct structural analysis according to established techniques [14] [15] . In all cases the variant was present in the heterozygous state and the abnormal fraction amounted to 31-44% of the total haemoglobin.
Blood glucose. This was measured on heparinized venous blood samples by a glucose-oxidase technique (Boehringer, Mannheim, FRG).
Calculations. A mean blood glucose value was calculated in each patient from 6-15 fasting and post-prandial determinations for the preceding 6 weeks. The regression line of the HbA1 versus glucose values and the corresponding 95% confidence limits were calculated from the data relative to the 360 reference diabetic patients.
Statistical analysis. The regression lines were calculated according to classical methods [16] . 
Results
HbA t and glucose correlation
In the reference diabetic group, there was a significant correlation between the HbA1 and glucose values ( Fig.l; In the patients with haemoglobinopathies (HbS, n =17; HbC, n --8; HbD Pundjab, n --1; HbE, n =2; [~ thalassaemia, n =1), all apparent HbA1 values were outside the 95% confidence limits constructed from the reference group. In the patients with C, D, E and S haemoglobins, the measured HbAa values fell below these limits. A good correlation was found between these apparent HbA~ values and the corresponding glucose concentration. However, the slope of the regression line was shallower than for the reference group (y=0.30x +2.50). In contrast, in the patient with heterozygous [~ thalassaemia (with HbF and A2), the HbAa value was above these limits.
The inspection of chromatography columns readily detected the abnormal haemoglobins C, D and S. The fractions D and S appeared as slow migrating bands with a rf approximately half that of normal haemoglobin (HbA0). The C fraction presented as a thin band which stuck to the top of the column. In the [3 -thalasaemic patient, HbF was not detected by the examination of the columns, since it moved faster than HbA0, and co-eluted with the HbA1 fraction.
Discussion
A highly significant correlation was found between HbAI and glucose concentration in the reference diabetic group. The patients with haemoglobinopathies had values outside the 95% confidence limits. The presence of haemoglobins S, C, D, E led to the under-estimation of HbAt and overestimation in a patient with thalassaemia. The haemoglobins S, C, D and E are more positively charged compared with HbA, hence elution from the cation exchange resin is retarded. The fast-moving fraction then corresponds only to the glycosylated HbA, which represents only a part of total haemoglobin [17] [18] [19] [20] . Conversely, HbF is more negatively charged than HbA and co-eluates with HbAtc on cation exchange chromatography, leading to an over-estimation of this fraction [21] . The same occurs with the rare, fast-moving varients HbK, I, J, with HbH in some [~ thalassaemia patients [20] [21] [22] and HbF in patients with [~ thalassaemia, hereditary persistence of fetal haemoglobin and acquired HbF [23] .
The concept of haemoglobin variants interfering with the measurement of glycosylated haemoglobin by ion exchange chromatography is not new [1, 24] . However, this problem has not received wide attention. It was a potential cause of misinterpretation in 6.9% of our patients, due to the large number of patients from countries with a high prevalence of haemoglobinopathies. Since the HbA1 assay has been proposed for the screening of diabetes among large population groups [19] , the interference of haemoglobin variants with this determination must be known, particularly in ethnic groups with a high incidence of haemoglobin variants. It is of interest that HbAI measurements in diabetic patients led to the description of two hitherto undescribed haemoglobin variants [25, 26] . In diabetic subjects with congenitally abnormal haemoglobin, the percentage of a haemoglobin variant can be measured by electrophorests, thus allowing corrections of HbA1 values. However, it may be advisable, in such patients, to measure haemoglobin glycosylation by either chemical methods or affinity chromatography on aminophenyl boronic acid resins [27] .
